for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

AbbVie's u-turn hurts hedge funds too

Posted

U.S. drugmaker AbbVie has pulled the plug on its $55 bln plan to buy Dublin-based Shire. Hayley Platt looks at the wider implications of their decision.

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up